Identification and characterization of impurities of tetracosactide by capillary electrophoresis and liquid chromatography coupled to time-of-flight mass spectrometry
Tetracosactide is a synthetic peptide analogue of the human adrenocorticotropic hormone that stimulates the production of cortisol in the adrenal cortex. The medical use of the compound is primarily the diagnosis of the adrenal cortex function. In order to characterize impurities of the drug, tetracosactide samples were analysed by both liquid chromatography and capillary electrophoresis coupled to a quadrupole time-of-flight mass spectrometer. The identification of the impurities was carried out based on accurate mass determination and fragment ion spectra. The presence of several peptides of lower and higher masses than tetracosactide could be shown, including N- and C-terminally truncated peptides as well as peptides which still contained protecting groups or additional amino acids. Furthermore, a semi-quantitative estimation of the relative amounts of the impurities in different samples as well as a commercial preparation revealed that the number and the type of the impurities varied between the samples. Comparing the selectivity of liquid chromatography and capillary electrophoresis regarding the separation of tetracosactide impurities, it can be stated that capillary electrophoresis showed a higher suitability for the separation of tetracosactide fragments (smaller peptides) while the larger peptides, i.e. those wearing protecting groups, were separated more efficiently by liquid chromatography.
KeywordsTetracosactide Impurity identification LC/MS CE/MS
The Federal Institute for Drugs and Medical Devices (BfArM, Bonn, Germany) is gratefully acknowledged for providing the samples of TCS and its impurities. AT thanks the Thomas Gessmann Foundation for financial support.
- 2.Toft A, Irvine W (1974) Hormonal Effects of Synthetic ACTH Analogues. Proc R Soc Med 67:749–750Google Scholar
- 12.WADA (2011) The 2011 Prohibited List. http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/To_be_effective/WADA_Prohibited_List_2011_EN.pdf. Accessed Jan 18 2011
- 17.Tetracosactide (2011) In: European Pharmacopoeia. 7th edn. European Directorate of The Quality of Medicines, Strasbourg, p monograph 0644Google Scholar
- 18.(2011) https://extranet.edqu.eu/4DLink1/pdfs/chromatos/0644.pdf. Accessed April 20
- 20.Kates SA, Albericio F (eds) (2000) Solid-Phase Synthesis: A Practical Guide. Marcel Dekker, Inc., New YorkGoogle Scholar
- 21.Chan WC, White PD (eds) (2000) Fmoc Solid Phase Peptide Synthesis - A Practical Approach. Oxford University Press, OxfordGoogle Scholar
- 28.Jalali-Heravi M, Shen Y, Hassanisadi M, Khaledi MG (2005) Prediction of electrophoretic mobilities of peptides in capillary zone electrophoresis by quantitative structure-mobility relationships using the offord model and artificial neural networks. Electrophoresis 26(10):1874–1885CrossRefGoogle Scholar
- 32.Petritis K, Kangas LJ, Yan B, Monroe ME, Strittmatter EF, Qian W-J, Adkins JN, Moore RJ, Xu Y, Lipton MS, Camp DG, Smith RD (2006) Improved Peptide Elution Time Prediction for Reversed-Phase Liquid Chromatography-MS by Incorporating Peptide Sequence Information. Anal Chem 78(14):5026–5039CrossRefGoogle Scholar
- 36.Sanz-Nebot V, Toro I, Castillo A, Barbosa J (2001) Investigation of synthetic peptide hormones by liquid chromatography coupled to pneumatically assisted electrospray ionization mass spectrometry: analysis of a synthesis crude of peptide triptorelin. Rapid Commun Mass Spectrom 15(13):1031–1039CrossRefGoogle Scholar